• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Sotatercept (Winrevair) Approved
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

Do I Need a Right Heart Catheterization?

September 25, 2015 By Dr. Jeremy Feldman

It is important to assess the right ventricle of the heart of PH patients

This question comes up all the time in the evaluation and care of pulmonary hypertension patients.  We have received a number of questions from readers asking about whether a heart catheterization is needed.  I thought it might be useful to review some basics about right heart catheterization.  Below are some commonly asked questions about the procedure. 1.      Do I need to … [Read more...]

Diuretics and Pulmonary Hypertension

September 23, 2015 By Dr. Jeremy Feldman

2 liter fluid restriction for PH patients

Diuretics are medications that increase your urine production.  Most patients with PAH require diuretics at some point in their disease course.  This is due to abnormal hormone signals that are produced by your heart, lungs and kidneys that lead to inappropriate fluid retention.  In health, your salt and water balance in your body is carefully regulated.  If you eat a salty … [Read more...]

Sildenafil (Revatio): Getting the Most Out of Your Medication

September 11, 2015 By Dr. Jeremy Feldman

Generic medications for PH

Sildenafil (Revatio) was approved in 2005 based on a 12-week study that showed improvements in six minute walk distance. In the initial study, there was not a clear difference between 20mg three times a day and higher doses. In a subsequent study that followed patients for years, the majority of patients increased their dose to 80mg three times daily and had lasting benefit. In … [Read more...]

Opsumit (Macitentan): Getting the Most From Your Medication

September 8, 2015 By Dr. Jeremy Feldman

PAH Physician

FDA Approval of Opsumit This medicine, Opsumit (Macitentan), was approved in 2014 based on a very large long-term study of 742 patients.  250 were randomized to placebo (sugar pill), 250 were randomized to 3mg once daily of Opsumit, and 242 were randomized to 10mg once daily.  Patients were then followed and their rates of clinical deterioration were recorded.  Exercise … [Read more...]

Common Medications that Pose Increased Risk in Pulmonary Hypertension

August 31, 2015 By Dr. Jeremy Feldman

Pharmacist trying to fill PAH medication

Non-Steroidal Anti-Inflammatory pain medications (NSAIDS) Non-Steroidal Anti-Inflammatory pain medications (NSAIDS) such as ibuprofen (Motrin), naproxen (Aleve), Etodolac, celecoxib (Celebrex) are all effective medications for mild to moderate pain.  However, all these medications also put increased stress on your kidneys.  In PAH, the kidneys are already under stress from … [Read more...]

« Previous Page
Next Page »

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

generic medication

Generic Adcirca is Coming!

By Dr. Jeremy Feldman

After many years under patent protection, the generic medication Tadalafil will soon be available. What does this mean

pulmonary hypertension research laboratory

Pulmonary Arterial Hypertension Research

By Dr. Jeremy Feldman

FDA Approval Process for PAH Drugs The past decade has seen many new drugs approved to treat PAH.  The development of a

good news in pah

 

Disclaimer

Recent Blog Posts

  • Making Order from Chaos October 26, 2025
  • Sotatercept: ZENITH and HYPERION Trials June 22, 2025
  • In Memoriam:  Greg Ahearn, MD June 16, 2024

Categories

Archives